BD
Therapeutic Areas
199 Biotechnologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| E-ON-001 | Glioblastoma | Preclinical |
| Senolytic Polyphenol Compound (PCC1) | Healthspan extension / Senescence clearance | Research |
| AgeQuant Diagnostic Platform | Longevity biomarker testing | Commercial |